RU2008142834A - Модуляция церамидкиназы - Google Patents
Модуляция церамидкиназы Download PDFInfo
- Publication number
- RU2008142834A RU2008142834A RU2008142834/04A RU2008142834A RU2008142834A RU 2008142834 A RU2008142834 A RU 2008142834A RU 2008142834/04 A RU2008142834/04 A RU 2008142834/04A RU 2008142834 A RU2008142834 A RU 2008142834A RU 2008142834 A RU2008142834 A RU 2008142834A
- Authority
- RU
- Russia
- Prior art keywords
- carboxamide
- benzothiazolyl
- compound according
- tricyclo
- decane
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims abstract 15
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract 8
- 125000003118 aryl group Chemical group 0.000 claims abstract 6
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract 6
- -1 1-oxohexadecyl Chemical group 0.000 claims abstract 5
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims abstract 4
- 125000005605 benzo group Chemical group 0.000 claims abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract 4
- HJEAQCSRJSVBMG-UHFFFAOYSA-N C12(CC3CC(CC(C1)C3)C2)C(=O)NC=2SC3=C(N2)C=CC(=C3)C3C2(CC1CC(CC3C1)C2)C(=O)N Chemical compound C12(CC3CC(CC(C1)C3)C2)C(=O)NC=2SC3=C(N2)C=CC(=C3)C3C2(CC1CC(CC3C1)C2)C(=O)N HJEAQCSRJSVBMG-UHFFFAOYSA-N 0.000 claims abstract 3
- 125000001931 aliphatic group Chemical group 0.000 claims abstract 3
- 125000004429 atom Chemical group 0.000 claims abstract 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims abstract 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims abstract 3
- CTGIQLKLIKLYOS-UHFFFAOYSA-N n-(2-acetamido-1,3-benzothiazol-6-yl)adamantane-1-carboxamide Chemical compound C1C(C2)CC(C3)CC2CC13C(=O)NC1=CC=C2N=C(NC(=O)C)SC2=C1 CTGIQLKLIKLYOS-UHFFFAOYSA-N 0.000 claims abstract 3
- 125000001424 substituent group Chemical group 0.000 claims abstract 3
- 125000005842 heteroatom Chemical group 0.000 claims abstract 2
- JNIVQDXIYUVIKT-UHFFFAOYSA-N n-(2-acetamido-1,3-benzothiazol-6-yl)-3-chloro-1-benzothiophene-2-carboxamide Chemical compound S1C2=CC=CC=C2C(Cl)=C1C(=O)NC1=CC=C2N=C(NC(=O)C)SC2=C1 JNIVQDXIYUVIKT-UHFFFAOYSA-N 0.000 claims abstract 2
- APTBRECSEHMDBC-UHFFFAOYSA-N n-(2-benzamido-1,3-benzothiazol-6-yl)-3-chloro-1-benzothiophene-2-carboxamide Chemical compound S1C2=CC=CC=C2C(Cl)=C1C(=O)NC(C=C1S2)=CC=C1N=C2NC(=O)C1=CC=CC=C1 APTBRECSEHMDBC-UHFFFAOYSA-N 0.000 claims abstract 2
- IYSOIVAMJRSOHU-UHFFFAOYSA-N n-[2-(butanoylamino)-1,3-benzothiazol-6-yl]-1-benzofuran-2-carboxamide Chemical compound C1=CC=C2OC(C(=O)NC3=CC=C4N=C(SC4=C3)NC(=O)CCC)=CC2=C1 IYSOIVAMJRSOHU-UHFFFAOYSA-N 0.000 claims abstract 2
- BLTXZJFWUDMWLQ-UHFFFAOYSA-N n-[2-(butanoylamino)-1,3-benzothiazol-6-yl]-2,3-dihydro-1,4-benzodioxine-6-carboxamide Chemical compound O1CCOC2=CC(C(=O)NC3=CC=C4N=C(SC4=C3)NC(=O)CCC)=CC=C21 BLTXZJFWUDMWLQ-UHFFFAOYSA-N 0.000 claims abstract 2
- VNTMNDBQSOYJFS-UHFFFAOYSA-N n-[2-(butanoylamino)-1,3-benzothiazol-6-yl]-3-chloro-1-benzothiophene-2-carboxamide Chemical compound S1C2=CC=CC=C2C(Cl)=C1C(=O)NC1=CC=C2N=C(NC(=O)CCC)SC2=C1 VNTMNDBQSOYJFS-UHFFFAOYSA-N 0.000 claims abstract 2
- LVEABWUIXLOSGS-UHFFFAOYSA-N n-[2-(cyclohexanecarbonylamino)-1,3-benzothiazol-6-yl]adamantane-1-carboxamide Chemical compound N=1C2=CC=C(NC(=O)C34CC5CC(CC(C5)C3)C4)C=C2SC=1NC(=O)C1CCCCC1 LVEABWUIXLOSGS-UHFFFAOYSA-N 0.000 claims abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract 2
- 229910052760 oxygen Inorganic materials 0.000 claims abstract 2
- 229910052717 sulfur Inorganic materials 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- KJECSSPZYXXDQX-UHFFFAOYSA-N C(C1=CC=CC=C1)(=O)NC=1SC2=C(N1)C=CC(=C2)C2C1(CC3CC(CC2(C3)C3=CC=CC=C3)C1)C(=O)N Chemical compound C(C1=CC=CC=C1)(=O)NC=1SC2=C(N1)C=CC(=C2)C2C1(CC3CC(CC2(C3)C3=CC=CC=C3)C1)C(=O)N KJECSSPZYXXDQX-UHFFFAOYSA-N 0.000 claims 1
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- MVSSJPGNLQPWSW-UHFFFAOYSA-N n-(2-benzamido-1,3-benzothiazol-6-yl)adamantane-1-carboxamide Chemical compound N=1C2=CC=C(NC(=O)C34CC5CC(CC(C5)C3)C4)C=C2SC=1NC(=O)C1=CC=CC=C1 MVSSJPGNLQPWSW-UHFFFAOYSA-N 0.000 claims 1
- KOUHBMWJVVCBCI-UHFFFAOYSA-N n-[6-(tetradecanoylamino)-1,3-benzothiazol-2-yl]benzamide Chemical compound S1C2=CC(NC(=O)CCCCCCCCCCCCC)=CC=C2N=C1NC(=O)C1=CC=CC=C1 KOUHBMWJVVCBCI-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229940124531 pharmaceutical excipient Drugs 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Transplantation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0606429.9 | 2006-03-30 | ||
| GBGB0606429.9A GB0606429D0 (en) | 2006-03-30 | 2006-03-30 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2008142834A true RU2008142834A (ru) | 2010-05-10 |
Family
ID=36424929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2008142834/04A RU2008142834A (ru) | 2006-03-30 | 2007-03-28 | Модуляция церамидкиназы |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20090170914A1 (zh) |
| EP (1) | EP2004617A2 (zh) |
| JP (1) | JP2009531365A (zh) |
| KR (1) | KR20080098443A (zh) |
| CN (1) | CN101415695A (zh) |
| AU (1) | AU2007234022A1 (zh) |
| BR (1) | BRPI0709270A2 (zh) |
| CA (1) | CA2644636A1 (zh) |
| GB (1) | GB0606429D0 (zh) |
| MX (1) | MX2008012399A (zh) |
| RU (1) | RU2008142834A (zh) |
| WO (1) | WO2007112914A2 (zh) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| JP5930205B2 (ja) * | 2010-08-26 | 2016-06-08 | 国立大学法人京都大学 | 多能性幹細胞の心筋分化促進剤 |
| US9499790B2 (en) | 2010-08-26 | 2016-11-22 | Kyoto University | Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells |
| WO2012029994A1 (en) * | 2010-09-02 | 2012-03-08 | Kyoto University | Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis |
| US8901114B2 (en) | 2011-03-08 | 2014-12-02 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
| WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120056A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| WO2013111875A1 (ja) | 2012-01-27 | 2013-08-01 | 国立大学法人京都大学 | 多能性幹細胞の心筋分化誘導法 |
| EP2966166B1 (en) | 2013-03-08 | 2019-04-03 | Kyoto University | Promoter of differentiation of pluripotent stem cell into myocardium, which comprises egf receptor inhibitor |
| EP3466955B1 (en) | 2014-01-13 | 2020-12-16 | Aurigene Discovery Technologies Limited | Method of preparing oxazolo[4,5-b]pyridine and thiazolo[4,5-b]pyridine derivatives as irak4 inhibitors for treating cancer |
| US10233426B2 (en) | 2014-05-30 | 2019-03-19 | Kyoto University | Method for inducing cardiac differentiation of pluripotent stem cell with low-molecular compounds |
| JP2018524365A (ja) * | 2015-07-15 | 2018-08-30 | アウリジーン ディスカバリー テクノロジーズ リミテッド | Ｉｒａｋ−４阻害剤としての置換アザ化合物 |
| JP6984854B2 (ja) * | 2015-10-08 | 2021-12-22 | 国立大学法人千葉大学 | ニーマン・ピック病ｃ型を予防または治療するための医薬組成物 |
| EP4252853A3 (en) | 2017-03-31 | 2023-12-13 | Aurigene Oncology Limited | Compounds and compositions for treating hematological disorders |
| US11548893B2 (en) | 2017-07-15 | 2023-01-10 | Arisan Therapeutics Inc. | Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection |
| CN108107147B (zh) * | 2017-08-23 | 2020-09-15 | 湖南省妇幼保健院 | 亚临床盆腔炎性疾病标志物及其用途 |
| IL308364A (en) | 2017-10-31 | 2024-01-01 | Curis Inc | Compounds and preparations for the treatment of hematological disorders |
| CN111763201A (zh) * | 2020-03-03 | 2020-10-13 | 中国药科大学 | 苯并噻唑类化合物及医药用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6323201B1 (en) * | 1994-12-29 | 2001-11-27 | The Regents Of The University Of California | Compounds for inhibition of ceramide-mediated signal transduction |
| KR20020084116A (ko) * | 2000-02-07 | 2002-11-04 | 애보트 게엠베하 운트 콤파니 카게 | 2-벤조티아졸릴 우레아 유도체 및 이의 단백질 키나제억제제로서의 용도 |
| WO2003030902A1 (en) * | 2001-10-09 | 2003-04-17 | Tularik Inc. | Imidazole derivates as anti-inflammatory agents |
| WO2003035602A1 (fr) * | 2001-10-25 | 2003-05-01 | Sankyo Company, Limited | Modulateurs lipidiques |
| TW200306819A (en) * | 2002-01-25 | 2003-12-01 | Vertex Pharma | Indazole compounds useful as protein kinase inhibitors |
| WO2004014905A1 (en) * | 2002-08-08 | 2004-02-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted benzimidazole compounds |
| CA2553966A1 (en) * | 2004-01-23 | 2005-08-04 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
-
2006
- 2006-03-30 GB GBGB0606429.9A patent/GB0606429D0/en not_active Ceased
-
2007
- 2007-03-28 WO PCT/EP2007/002765 patent/WO2007112914A2/en active Application Filing
- 2007-03-28 AU AU2007234022A patent/AU2007234022A1/en not_active Abandoned
- 2007-03-28 JP JP2009501945A patent/JP2009531365A/ja active Pending
- 2007-03-28 CN CNA2007800119536A patent/CN101415695A/zh active Pending
- 2007-03-28 US US12/295,375 patent/US20090170914A1/en not_active Abandoned
- 2007-03-28 EP EP07723710A patent/EP2004617A2/en not_active Withdrawn
- 2007-03-28 KR KR1020087023763A patent/KR20080098443A/ko not_active Application Discontinuation
- 2007-03-28 CA CA002644636A patent/CA2644636A1/en not_active Abandoned
- 2007-03-28 RU RU2008142834/04A patent/RU2008142834A/ru not_active Application Discontinuation
- 2007-03-28 MX MX2008012399A patent/MX2008012399A/es not_active Application Discontinuation
- 2007-03-28 BR BRPI0709270-9A patent/BRPI0709270A2/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20090170914A1 (en) | 2009-07-02 |
| WO2007112914A2 (en) | 2007-10-11 |
| EP2004617A2 (en) | 2008-12-24 |
| KR20080098443A (ko) | 2008-11-07 |
| BRPI0709270A2 (pt) | 2011-06-28 |
| AU2007234022A1 (en) | 2007-10-11 |
| GB0606429D0 (en) | 2006-05-10 |
| MX2008012399A (es) | 2008-10-09 |
| CA2644636A1 (en) | 2007-10-11 |
| CN101415695A (zh) | 2009-04-22 |
| WO2007112914A3 (en) | 2007-11-29 |
| JP2009531365A (ja) | 2009-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2008142834A (ru) | Модуляция церамидкиназы | |
| RU2397168C2 (ru) | Производные тиофена в качестве ингибиторов снк 1 | |
| ES2622881T3 (es) | Compuestos de N-heteroarilo | |
| BRPI0412761A (pt) | inibidores de serino proteases, particularmente a protease ns3-ns4a do vhc | |
| EA201500266A1 (ru) | Ингибиторы репликации вирусов гриппа | |
| EA200971041A1 (ru) | Новые пептидные ингибиторы репликации вируса гепатита с | |
| EA200900358A1 (ru) | Энантиомерно чистые фосфоиндолы в качестве ингибиторов hiv | |
| RU2008126228A (ru) | 2-аминобензамидное производное | |
| RU2011106374A (ru) | Циклические ингибиторы 11бета-гидроксистероид-дегидрогеназы 1 | |
| RU2012104214A (ru) | Противовирусные соединения и способы их получения и применения | |
| AR072471A1 (es) | BENZOXACINAS Y BENZOTIACINAS CON ACTIVIDAD INHIBIDORA DE NOS, COMPOSICIoN FARMACÉUTICA QUE LAS COMPRENDE Y SU USO EN EL TRATAMIENTO DEL DOLOR. | |
| EA200500846A1 (ru) | Замещенные арилтиомочевины и родственные соединения; ингибиторы вирусной репликации | |
| AR037996A1 (es) | Compuesto derivado de amino nicotinato, composicion farmaceutica; proceso para su preparacion y su uso como medicamento | |
| EA201170969A1 (ru) | Новые макроциклические ингибиторы репликации вируса гепатита с | |
| RU2008107733A (ru) | Ингибиторы gsk-3 | |
| RU2007101685A (ru) | Модуляторы никотиновых ацетилхолиновых рецепторов альфа 7 и их терапевтические применения | |
| RU2009118254A (ru) | Фенилацетамиды в качестве ингибиторов протеинкиназ | |
| AR038863A1 (es) | Uso de un inhibidor de garft y/o de aicarft y de un agente antitoxico para preparar un medicamento para destruir selectivamente celulas mtap-deficientes de un mamifero | |
| HK1101402A1 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| RU2008129723A (ru) | Ингибиторы ccr9 активности | |
| AR035069A1 (es) | Compuestos inhibidores de espiropirimidin-2,4,6-triona metaloproteinasas, composicion farmaceutica, procedimiento de tratamiento | |
| EA200500610A1 (ru) | Композиция для лечения инфекции, вызываемой вирусами семейств flaviviridae | |
| PE20061156A1 (es) | Derivados de benzamida como agentes inhibidores del transportador de glicina | |
| RU2006137079A (ru) | Производные а-аминоамида, полезные при лечении синдрома усталых ног и вызывающих привыкание расстройств | |
| RU2010107603A (ru) | Производные n-(2-тиазолил)амида для лечения ожирения, диабетов и сердечно-сосудистых заболеваний |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20110214 |